Figure 1

Frequencies of reported psoriasis AEs in RA patients undergoing TNF inhibitor monotherapy. Methotrexate is the control shown in red.

Frequencies of reported psoriasis AEs in RA patients undergoing TNF inhibitor monotherapy. Methotrexate is the control shown in red.